Fast Track Initiative, Inc. logo

Fast Track Initiative, Inc.

Asia, Tokyo, Japan, Hongo

Description

Fast Track Initiative is a venture capital firm in Japan and the US with an exclusive focus on life sciences and healthcare.

Investor Profile

Fast Track Initiative, Inc. has made 11 investments, with 2 in the past 12 months and 27% as lead.

Stage Focus

  • Series B (36%)
  • Series A (27%)
  • Series Unknown (18%)
  • Seed (9%)
  • Series C (9%)

Country Focus

  • Japan (64%)
  • United States (27%)
  • United Kingdom (9%)

Industry Focus

  • Health Care
  • Biotechnology
  • Medical
  • Therapeutics
  • Alternative Medicine
  • Clinical Trials
  • Pharmaceutical
  • Nursing And Residential Care
  • Life Science
  • Health Diagnostics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fast Track Initiative, Inc. frequently co-invest with?

UTokyo Innovation Platform
Asia, Tokyo, Japan, Tokyo
Co-Investments: 3
FFG Venture Business Partners
Asia, Fukuoka, Japan, Fukuoka
Co-Investments: 1
Pegasus Tech Ventures
North America, California, United States, San Jose
Co-Investments: 1
SMBC Venture Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 3
Shinsei Capital Partners
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
SBI Investment
Asia, Chiba, Japan, Minato
Co-Investments: 1
CareNet
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Mizuho Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
Keio Innovation Initiative
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
Mitsubishi UFJ Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2

Which angels does Fast Track Initiative, Inc. often collaborate with?

Shared Deals: 1

What are some of recent deals done by Fast Track Initiative, Inc.?

RegCell

Osaka, Osaka, Japan

RegCell is a novel therapeutics company.

Alternative MedicineClinical TrialsOutpatient Care
SeedMar 18, 2025
Amount Raised: $8,500,000
Neusignal Therapeutics

Tokyo, Tokyo, Japan

Neusignal Therapeutics is a medical company that develops therapeutic medicines for dementia and psychiatric illnesses.

BiotechnologyHealth CareHealth DiagnosticsTherapeutics
Series AJan 31, 2025
Amount Raised: $7,409,553
Shinobi Therapeutics

South San Francisco, California, United States

Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment.

BiotechnologyHealth CareTherapeutics
Series ADec 12, 2023
Amount Raised: $51,000,000
AIRNA

Cambridge, Massachusetts, United States

AIRNA is a biotech company that is pioneering RNA editing therapies to improve the health of individuals.

BiotechnologyHealth CareMedical
Series ASep 19, 2023
Amount Raised: $30,000,000
Storm Therapeutics

Cambridge, Cambridgeshire, United Kingdom

Targeting pathways that modify RNA to deliver novel cancer therapeutics

BiotechnologyHealth CareMedicalTherapeutics
Series BDec 14, 2022
Amount Raised: $30,000,000
LUCA Science

Tokyo, Tokyo, Japan

LUCA Science develops innovative treatments intended for mitochondrial and related diseases.

BiotechnologyHealth CarePharmaceutical
Series BJun 6, 2022
Amount Raised: $29,203,600
Celsius Therapeutics

Cambridge, Massachusetts, United States

Celsius Therapeutics is a biotechnology company that develops precision medicines for cancer and autoimmune disease patients.

BiotechnologyEmergency MedicineGeneticsHealth CarePrecision Medicine
Series BMar 24, 2022
Amount Raised: $83,000,000
Modulus Discovery

Tokyo, Tokyo, Japan

Modulus Discovery is a preclinical-stage technology-driven drug discovery firm.

BiotechnologyClinical TrialsMedicalNursing and Residential CarePharmaceutical
Series CMar 1, 2022
Amount Raised: $20,375,909
Mentalhealth Technologies

Tokyo, Tokyo, Japan

Mentalhealth Technologies is a health care company.

BeautyEducationEmploymentHealth CareHuman ResourcesMedicalNursing and Residential CareSocial MediaTask ManagementVideo
Series UnknownApr 27, 2020
Amount Raised: $2,236,830
Modalis Therapeutics

Tokyo, Tokyo, Japan

Modalis is an biotech company that develops therapeutics using CRISPR based technology.

BiotechnologyHealth CareLife Science
Series BApr 10, 2019
Amount Raised: $25,000,000